When analyzing the biology behind the molecular
alterations in these tumors, the researchers found that nearly three - quarters of cervical cancers had genomic alterations in either one or both of the PI3K / MAPK and TGF - beta signaling pathways, which may also provide targets for therapy.
Although therapies tailored based on genetic
alterations in these tumors have been developed, their benefit is usually short - lived.
Errors in chromosome segregation can cause birth defects and embryonic lethality in humans and cause aneuploidy, the most common genetic
alteration in tumors.
DNA Detectives Find Genetic Markers for Lung Cancers Most Likely to Recur Researchers at the Johns Hopkins Kimmel Cancer Center uncovered clearly recognizable genetic
alterations in tumors and tissue removed from patients with early - stage lung cancers that look like good predictors of which of these cancers are more likely to recur.
Not exact matches
The discovery of anticancer drugs is now driven by the numerous molecular
alterations identified
in tumor cells over the past decade.
Among patients with non-small cell lung cancer (NSCLC) fueled by ALK gene
alterations who were being treated with crizotinib (Xalkori), a decrease
in the number of circulating
tumor cells (CTCs) harboring increased copies of the ALK gene over the first two months of treatment was associated with increased progression - free survival.
The
tumors» genomes were then analyzed for genetic mutations, or
alterations in their DNA, by her team and that of Bert Vogelstein, M.D., professor of oncology at the Johns Hopkins University School of Medicine and the co-director of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center.
Through their analysis, the researchers determined the genetic
alterations found
in both the primary
tumors and the metastases frequently were a type of genetic abnormality called a copy number
alteration, which is when sections of DNA are repeated (i.e. duplicated).
In experiments with cancer cell lines, the PIM1 inhibitors killed cells in a MYC - dependent manner, and in two different mouse models — one in which mice were implanted with patient tumors and the other in which a genetic alteration of MYC predisposes the mice to tumor development — the administration of PIM1 inhibitors resulted in significant tumor regressio
In experiments with cancer cell lines, the PIM1 inhibitors killed cells
in a MYC - dependent manner, and in two different mouse models — one in which mice were implanted with patient tumors and the other in which a genetic alteration of MYC predisposes the mice to tumor development — the administration of PIM1 inhibitors resulted in significant tumor regressio
in a MYC - dependent manner, and
in two different mouse models — one in which mice were implanted with patient tumors and the other in which a genetic alteration of MYC predisposes the mice to tumor development — the administration of PIM1 inhibitors resulted in significant tumor regressio
in two different mouse models — one
in which mice were implanted with patient tumors and the other in which a genetic alteration of MYC predisposes the mice to tumor development — the administration of PIM1 inhibitors resulted in significant tumor regressio
in which mice were implanted with patient
tumors and the other
in which a genetic alteration of MYC predisposes the mice to tumor development — the administration of PIM1 inhibitors resulted in significant tumor regressio
in which a genetic
alteration of MYC predisposes the mice to
tumor development — the administration of PIM1 inhibitors resulted
in significant tumor regressio
in significant
tumor regression.
They didn't develop
tumors any faster than normal, and they didn't have any
alterations in their blood vessels, which the researchers had anticipated based on BAI1's role
in regulating blood vessel growth.
The new study, a comprehensive analysis of the genomes of 178 primary cervical cancers, found that over 70 percent of the
tumors had genomic
alterations in either one or both of two important cell signaling pathways.
In a report on one of the two findings, published online Sept. 20 in Acta Neuropathologica, the investigators identified alterations in a protein known as ATRX in human brain tumors that arise as part of a genetically inherited condition known as neurofibromatosis type 1 (NF1
In a report on one of the two findings, published online Sept. 20
in Acta Neuropathologica, the investigators identified alterations in a protein known as ATRX in human brain tumors that arise as part of a genetically inherited condition known as neurofibromatosis type 1 (NF1
in Acta Neuropathologica, the investigators identified
alterations in a protein known as ATRX in human brain tumors that arise as part of a genetically inherited condition known as neurofibromatosis type 1 (NF1
in a protein known as ATRX
in human brain tumors that arise as part of a genetically inherited condition known as neurofibromatosis type 1 (NF1
in human brain
tumors that arise as part of a genetically inherited condition known as neurofibromatosis type 1 (NF1).
«
In extreme cases, if the dose is too high radiation can modify the cellular structure and generate alteration in the cells of organs found near the tumor, this causes them to lose their functions,» said Massillon, who was honored for her research with the IUPAP Young Scientist Prize 2015 awarded by the International Union of Pure and Applied Physic
In extreme cases, if the dose is too high radiation can modify the cellular structure and generate
alteration in the cells of organs found near the tumor, this causes them to lose their functions,» said Massillon, who was honored for her research with the IUPAP Young Scientist Prize 2015 awarded by the International Union of Pure and Applied Physic
in the cells of organs found near the
tumor, this causes them to lose their functions,» said Massillon, who was honored for her research with the IUPAP Young Scientist Prize 2015 awarded by the International Union of Pure and Applied Physics.
In this study, researchers assessed the outcomes of 280 prostate cancer (Cap) patients, and reviewed the DNA «fingerprints» of each patient's tumor (using the patient's initial diagnostic core biopsy) to determine if gene copy number alterations (CNAs), or breaks in CFSs, were related to a less positive response to treatmen
In this study, researchers assessed the outcomes of 280 prostate cancer (Cap) patients, and reviewed the DNA «fingerprints» of each patient's
tumor (using the patient's initial diagnostic core biopsy) to determine if gene copy number
alterations (CNAs), or breaks
in CFSs, were related to a less positive response to treatmen
in CFSs, were related to a less positive response to treatment.
A University of Colorado Cancer Center study published
in the journal Oncogene used next - generation sequencing technologies to perform the most detailed DNA - based analysis to date of 25 commonly used bladder cancer cell lines, allowing researchers to match patient
tumors with their closest genetic cell line match, and demonstrated genetic
alterations that may make cells more or less sensitive to common therapies.
Five of the 11 patients (45 percent) had «discrepant pathogenic
alterations»
in the metastasis that were not present
in the primary
tumor.
Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer
tumors through genomic profiling shows that
tumors with
alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the
tumor originated
in the body.
«We've analyzed epigenetic
alterations, namely the chemical signal called DNA methylation
in 500 breast
tumors and have compared the patterns obtained with the clinical behavior of these cancers,» says Esteller.
This study demonstrated that emulsifier - induced
alterations in the microbiome were necessary and sufficient to drive
alterations in intestinal epithelial cells» homeostasis, which is thought to govern
tumor development.
The effects of consuming emulsifiers were eliminated
in mice devoid of microbiota (germ - free mice), and transplanting microbiota from emulsifier - treated mice to germ - free mice was sufficient to transfer
alterations in intestinal epithelial cells» homeostasis, suggesting a central role played by the microbiota
in tumor development.
In a collaborative study, researchers from Chinese Academy of Medical Sciences and Peking Union Medical College, BGI, Shantou University Medical College and other institutions identified important alterations of tumor - associated genes and tumorigenic pathways in esophageal squamous cell cancer (ESCC), one of the leading cause of cancer death worldwid
In a collaborative study, researchers from Chinese Academy of Medical Sciences and Peking Union Medical College, BGI, Shantou University Medical College and other institutions identified important
alterations of
tumor - associated genes and tumorigenic pathways
in esophageal squamous cell cancer (ESCC), one of the leading cause of cancer death worldwid
in esophageal squamous cell cancer (ESCC), one of the leading cause of cancer death worldwide.
They found that early phenformin treatment causes increased survival and slower
tumor progression
in tumors lacking LKB1, but had no significant benefit for
tumors with
alterations in other lung cancer genes.
UNLABELLED: Cancer genome characterization efforts now provide an initial view of the somatic
alterations in primary
tumors.
I believe there are three highlights: frequent gene
alterations in TNBC, under - representation of mutations
in mRNA sequences, and a continuous distribution of mutation frequencies within
tumors.
The recommendation is due
in large part to a growing body of evidence demonstrating the clinical benefit of treating patients whose
tumors harbor this
alteration with targeted therapy.
The prevailing notion was that
tumors had from a few hundred up to 20,000 genetic
alterations that were not present
in the patientembers healthy cells.
Because DDX3 exhibits
tumor suppressor functions, such as a growth - suppressive property and transcriptional activation of the p21waf1 / cip1 promoter, and is inactivated through down - regulation of gene expression or
alteration of subcellular localization
in tumor cells, all these features together suggest that DDX3 might be a candidate
tumor suppressor.
To further confirm the
alteration of DDX3 expression
in cancer specimens, the expression profiles of DDX3 were examined
in normal -
tumor paired HCC samples by immunohistochemical staining analysis using specific anti-DDX3 antibody.
Aneuploidy (an abnormal number of chromosomes) is the most common genetic
alteration in human
tumors and a major cause for birth defects (Figure 4).
Genome - wide detection of SVs and copy number
alterations, which are often pervasive (and clinically relevant)
in tumor genomes
Errors
in chromosome segregation are a major cause for birth defects and embryonic lethality
in humans, and the most common genetic
alteration in human
tumors is aberrant chromosome numbers, called aneuploidy.
Perhaps surprisingly, the authors find that somatic mutations occur at a continuous distribution
in TNBC, and this appears independent of copy number
alterations and
tumor cellularity.
A clear and growing body of evidence supports the notion that epigenetic
alterations, such as DNA methylation, occur early
in and contribute to
tumor formation.
On the plus side, Aisner points out, testing via circulating
tumor DNA returns very few false - positives — when a test discovers DNA with a cancer - causing genetic change, it is strong evidence that this
alteration is,
in fact, present
in the patient's cancer.
The role of genetic
alterations in the microenvironment of sporadic and heritable breast carcinomas and other solid
tumors are being examined as they relate to clinical outcome.
The authors examined interactions between
tumor proliferation levels (Ki67), histological categories, intrinsic subtype, and somatic
alterations in these two categories of
tumors.
Of those, 40 percent had
tumors with
alterations in one of three NTRK genes and few other changes.
DATE: April 3 TIME: 4:05 p.m. LOCATION: Room 204, Level 2, Washington Convention Center TITLE: Comparison of somatic
alterations in the genome and transcriptome of 1,705 pediatric leukemia and solid
tumors: a report from the Children's Oncology Group (COG)- NCI TARGET Project ABSTRACT: 3004
The investigators also identified
alteration in NTRK genes that drove
tumor development
in young HGG patients whose
tumors developed outside the brainstem.
Epigenetic
alterations play a crucial role
in tumor progression.
Exome sequencing alone detected driver gene
alterations in 26 % of
tumors, compared to 72 % by genome sequencing.
These drugs mainly act against
tumors with one or more specific
alterations in their DNA.
We are also applying CRISPR / Cas9 - mediated genome engineering to develop novel mouse models
in order to explore the impact of gene dosage
alterations on
tumor development
in vivo.
About 90 % of solid
tumors display whole - chromosome aneuploidy, while many
tumors with diploid karyotypes nonetheless harbor segmental or arm - length aneuploidies that also result
in significant gene copy number
alterations.
The long - term goals of my laboratory are to understand how
alterations in the RB1 and TP53
tumor suppressor gene regulatory networks cause cancer.
SEngine
in - depth analysis of the MYC oncogene across 11,000 samples and 33
tumor types published
in Pan-cancer
Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Variations
in the genetic code, from single point mutations to large structural or copy number
alterations, influence susceptibility, onset, and progression of genetic diseases and
tumor transformation.
Autophagy is critical for pancreatic
tumor growth and progression
in tumors with p53
alterations.
Nowell, a
tumor biologist
in the pathology department at the University of Pennsylvania School of Medicine, was interested
in the relationship between cancer and
alterations in genes (although he had no proof there was one).
These three chromosome arms harbor well - known oncogenes and
tumor suppressor genes that have been shown to undergo copy number
alterations in many cancers, including BC (Vogelstein et al., 2013).